Russian Federation vs Saudi Arabia: Immunization, HepB3
Russian Federation
97.0%
in 2024
Saudi Arabia
97.0%
in 2024
Russian Federation rank
26th
Saudi Arabia rank
26th
Immunization, HepB3 over time
- Russian Federation
- Saudi Arabia
How they compare
Russian Federation currently reports 97.0% against 97.0% in Saudi Arabia, a difference of 0.0%.
The two have swapped places 4 times across 24 shared years of data; in 2001 it was Saudi Arabia ahead.
Russian Federation ranks 26th and Saudi Arabia ranks 26th of 188 countries.
Across the 3 decades both report, Russian Federation averaged higher in 1 and Saudi Arabia in 2.
Head to head by decade
| Decade | Russian Federation | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 89.2% | 96.4% | 7.2% | Saudi Arabia |
| 2010s | 97.0% | 97.7% | 0.7% | Saudi Arabia |
| 2020s | 97.0% | 96.8% | 0.2% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Russian Federation or Saudi Arabia?
- Russian Federation, at 97.0% against 97.0% in Saudi Arabia as of 2024.
- What is the difference in immunization, hepb3 between Russian Federation and Saudi Arabia?
- 0.0%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Saudi Arabia?
- 24 years are reported by both, from 2001 to 2024.
- How do Russian Federation and Saudi Arabia rank globally for immunization, hepb3?
- Russian Federation ranks 26th and Saudi Arabia ranks 26th of 188 countries.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.